This blog will explore the fundamental role of biocompatibility testing in medical device development, including the prevention of adverse biological reactions and compliance with ISO 10993 standards. It will cover how early testing and comprehensive documentation accelerate market approvals and reduce the risk of costly recalls, aligning with Eunoia’s personalized consultancy to ensure products meet these critical safety requirements.
